Entest Biomedical Valuation
| ETNI Stock | USD 0.0002 0.00 0.00% |
Entest Biomedical seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Entest Biomedical from reviewing the firm fundamentals such as Net Income of 191.62 K, cash and equivalents of 423.97 K, and Price To Earning of 4.49 X as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Entest Biomedical's price fluctuation is very steady at this time. Calculation of the real value of Entest Biomedical is based on 3 months time horizon. Increasing Entest Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Entest Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Entest Pink Sheet. However, Entest Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.79E-4 | Hype 2.5E-4 |
The intrinsic value of Entest Biomedical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Entest Biomedical's stock price.
Estimating the potential upside or downside of Entest Biomedical helps investors to forecast how Entest pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Entest Biomedical more accurately as focusing exclusively on Entest Biomedical's fundamentals will not take into account other important factors: About Entest Biomedical Valuation
An absolute valuation paradigm, as applied to Entest Pink Sheet, attempts to find the value of Entest Biomedical based on its fundamental and basic technical indicators. By analyzing Entest Biomedical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Entest Biomedical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Entest Biomedical. We calculate exposure to Entest Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Entest Biomedical's related companies.It intends to seek business opportunities to review and analyze for purposes of effecting a merger, acquisition, or other business combination with an operating company business. Entest Group, Inc. was founded in 2008 and is based in Shenzhen, China. Entest is traded on OTC Exchange in the United States.
8 Steps to conduct Entest Biomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Entest Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Entest Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Entest Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Entest Biomedical's revenue streams: Identify Entest Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Entest Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Entest Biomedical's growth potential: Evaluate Entest Biomedical's management, business model, and growth potential.
- Determine Entest Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Entest Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Entest Biomedical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 49.2 M | |
| Retained Earnings | -10.1 M |
Complementary Tools for Entest Pink Sheet analysis
When running Entest Biomedical's price analysis, check to measure Entest Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entest Biomedical is operating at the current time. Most of Entest Biomedical's value examination focuses on studying past and present price action to predict the probability of Entest Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entest Biomedical's price. Additionally, you may evaluate how the addition of Entest Biomedical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |